Develops innovative treatments for mucosal inflammatory diseases
Thabor's website
Thabor therapeutics is an INSERM spin off developing a first-in-class therapeutic antibody targeting AGR2 for the treatment of inflammatory mucosal diseases
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
SATT Ouest Valorisation Research, Startup accelerator & VC, Research Services | SATT Ouest Valorisation Research, Startup accelerator & VC, Research Services | Other 31 Mar 2024 | |